Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagenic Therapeutics Inc

3.62
+0.13503.87%
Post-market: 3.650.0300+0.83%19:55 EDT
Volume:95.25K
Turnover:343.48K
Market Cap:3.14M
PE:-0.23
High:3.67
Open:3.54
Low:3.52
Close:3.49
Loading ...

Company Profile

Company Name:
Protagenic Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
2
Office Location:
149 Fifth Avenue,Suite 500,New York,New York,United States
Zip Code:
10010
Fax:
- -
Introduction:
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Directors

Name
Position
Garo H. Armen
Executive Chairman
Brian Corvese
Director
Jennifer Buell
Director
Khalil Barrage
Director
Robert B. Stein
Director
Timothy R. Wright
Director

Shareholders

Name
Position
Alexander K. Arrow
Chief Financial Officer
Garo H. Armen
Executive Chairman